- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07622095
Validation of the French Version of the New Mobility Score (NMS) (MOB-SCORE)
Validation of the French Version of the New Mobility Score (NMS) in Hospitalized Patients With Hip Fracture
The incidence of hip fractures in France is 50,000 cases per year among women and 16,000 among men, with a 1-year mortality rate of 20-24%. After a fracture, 10-30% of patients become functionally dependent. The increasing aging of the population and the rise in dependency are likely to worsen the situation of older patients in hospital settings.
Several tools are available to assess functional independence, including the New Mobility Score (NMS), which evaluates mobility through three domains: mobility indoors, mobility outdoors, and shopping activities. The NMS has shown good performance in predicting patient mortality and functional recovery, and its use is recommended in clinical practice. However, the French version of the NMS has not yet been validated.
The French validation of the NMS is important to facilitate its implementation in clinical practice and research, particularly because of its simplicity and the need for rapid assessment tools for healthcare professionals. A French version of the NMS has been translated, and the MOB-SCORE study aims to assess its reliability and validity among healthcare professionals caring for patients with hip fractures.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Olivia FEBVEY-COMBES, MD
- Telefonnummer: +33 (0)4 72 11 51 62
- E-post: olivia.febvey-combes@chu-lyon.fr
Studiesteder
-
-
-
Lyon, Frankrike, 69004
- Rekruttering
- Service I3 de court séjour gériatrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
-
Ta kontakt med:
- Iago HUGHES SANMARTIN, Physiotherapist
- Telefonnummer: +33 (0)4 26 10 94 75
- E-post: Iago.hughes-sanmartin@chu-lyon.fr
-
Hovedetterforsker:
- Iago HUGHES SANMARTIN, Physiotherapist
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Patients aged 75 years and older admitted to a hospital department following a hip fracture and treated surgically (osteosynthesis or arthroplasty).
- Type of fracture: pertrochanteric fracture or femoral neck fracture.
- Sufficient proficiency in French to complete the questionnaires.
- Patients affiliated with a health insurance scheme.
- No objection to participate from the patient or the caregiver in case of cognitive impairment.
Exclusion Criteria: no exclusion criteria
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Subjects aged 75 years and over admitted to a hospital ward following a hip fracture
Subjects aged 75 years and over, admitted to a hospital service following a hip fracture (per trochanteric or femoral neck) and having received surgical treatment (osteosynthesis or arthroplasty).
|
New Mobility Score (NMS), Measure of Functional Independence (MIF), Cumulated Ambulation Score (CAS), Mini-Mental State Examination (MMSE).
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Inter-rater reliability of the New Mobility Score (NMS)
Tidsramme: Within 7 days following the fracture surgery
|
The New Mobility Score (NMS) assesses mobility in three domains (indoors, outdoors, and while shopping).
For each domain, a score ranging from 0 (unable to perform the task) to 3 (able to perform the task independently) is assigned, with a total score ranging from 0 to 9. A score of ≤6 indicates functional impairment, whereas a score of >6 indicates a high pre-fracture level of mobility in patients with hip fracture.
The NMS will be rated by a physiotherapist and an adapted physical activity (APA) instructor.
|
Within 7 days following the fracture surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Internal consistency of the New Mobility Score (NMS)
Tidsramme: Within 7 days following the fracture surgery
|
Internal consistency of the New Mobility Score (NMS) items.
|
Within 7 days following the fracture surgery
|
|
Convergent validity of the New Mobility Score (NMS) with other functional independence scales, cognitive status and age.
Tidsramme: Within 7 days following the fracture surgery
|
Correlation between the New Mobility Score (NMS) and:
|
Within 7 days following the fracture surgery
|
|
Predictive validity of mortality at postoperative day 30.
Tidsramme: Within 30 days following the fracture surgery
|
Correlation between the New Mobility Score (NMS) and vital status at postoperative day 30.
|
Within 30 days following the fracture surgery
|
|
Discriminatory validity based on place of residence.
Tidsramme: Within 7 days following the fracture surgery
|
Comparison of the New Mobility Score (NMS) according to pre-fracture living arrangements: living alone versus living in a nursing home/with family.
|
Within 7 days following the fracture surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sår og skader
- Beinskader
- Brudd, bein
- Femoral frakturer
- Hofteskader
- Patologiske tilstander, tegn og symptomer
- Tegn og symptomer
- Mobilitetsbegrensning
- Hoftebrudd
- Helsevesenets kvalitet, tilgang og evaluering
- Undersøkelsesteknikker
- Epidemiologiske metoder
- Datainnsamling
- Helsevesenets evalueringsmekanismer
- Kvalitet på helsehjelpen
- Folkehelse
- Miljø og folkehelse
- Undersøkelser og spørreskjemaer
Andre studie-ID-numre
- 69HCL25_0571
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .